SCHEMBL22927337

SCHEMBL22927337

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5c6cccc7c6c(cc54)-c4ccccc4-c4ccccc4-7)c3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ATM Q13315 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ HSD17B10 Q99714 4/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.34
▸ ABCG2 Q9UNQ0 4/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16999590 1.00 L3MBTL1 (0.37) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL22927313 0.91 L3MBTL1 (0.38) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL19918515 0.90 L3MBTL1 (0.38) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL20029579 0.90 HSD17B10 (0.38) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL19918518 0.89 L3MBTL1 (0.37) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL19918509 0.89 L3MBTL1 (0.37) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL12495973 0.89 L3MBTL1 (0.36) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL20391601 0.89 ALDH1A1 (0.36) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL17322150 0.89 L3MBTL1 (0.40) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL26730595 0.89 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024466-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024466-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ICOSLG, SOD1, OR10J3 L3MBTL1 152/4885KDM4E 892/4885ATM 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback